Delivery Order SPE2DB24D1007-SPE2DB25FCCVM
Award Date 8/13/25
Potential Completion Date 8/14/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,143.87 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (semaglutide), a GLP-1 receptor agonist medication commonly used for weight management and diabetes treatment. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,205.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist commonly prescribed for weight management. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,607.35 to AmerisourceBergen Drug Corp for ZEPBOUND 5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed-price, competitively awarded delivery order was issued on June 10, 2025, with an ultimate completion date of June 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,143.87 for the supply of Zepbound 2.5mg/0.5ml (semaglutide injection), a diabetes and weight management medication. This competitively awarded, firm fixed-price delivery order was issued on July 4, 2025, with an ultimate completion date of July 7, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,725.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens (semaglutide) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as the...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $22,782.76 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pen injections on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide injection) with an ultimate completion date of September 25, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens on September 27, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order represents a direct purchase of the FDA-approved diabetes and weight management medication through a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,143.87 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...